The University of Chicago Header Logo

Connection

Richard Schilsky to Biosimilar Pharmaceuticals

This is a "connection" page, showing publications Richard Schilsky has written about Biosimilar Pharmaceuticals.
Connection Strength

2.107
  1. Reply to S.D. Lucio. J Clin Oncol. 2018 07 10; 36(20):2127.
    View in: PubMed
    Score: 0.638
  2. Rationale, Opportunities, and Reality of Biosimilar Medications. N Engl J Med. 2018 May 24; 378(21):2036-2044.
    View in: PubMed
    Score: 0.638
  3. American Society of Clinical Oncology Statement: Biosimilars in Oncology. J Clin Oncol. 2018 04 20; 36(12):1260-1265.
    View in: PubMed
    Score: 0.626
  4. Use of Biosimilar Medications in Oncology. JCO Oncol Pract. 2022 Mar; 18(3):177-186.
    View in: PubMed
    Score: 0.205
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.